What is he best known for?
The fields of study he is best known for:
- Finance
- Health care
- Internal medicine
His primary areas of study are Productivity, Labour economics, Production, Capital and Total factor productivity.
His Productivity research is multidisciplinary, relying on both Output elasticity, Microeconomics, Investment and International economics.
His Labour economics research is multidisciplinary, incorporating elements of Function, Productivity paradox and Comparative advantage.
As a part of the same scientific family, Frank R. Lichtenberg mostly works in the field of Capital, focusing on Marginal rate of substitution and, on occasion, Physical capital and Capital intensity.
His Total factor productivity research incorporates themes from Diversification and Agricultural economics.
His Demographic economics course of study focuses on New Drug Approvals and Longevity and Life expectancy.
His most cited work include:
- The Comparative Advantage of Educated Workers in Implementing New Technology (821 citations)
- Does Foreign Direct Investment Transfer Technology Across Borders (489 citations)
- The Output Contributions Of Computer Equipment And Personnel: A Firm-Level Analysis (432 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Life expectancy, Longevity, Drug, Productivity and Medical prescription.
Frank R. Lichtenberg has researched Life expectancy in several fields, including Per capita income, Economic growth, Poverty and Public health.
The various areas that Frank R. Lichtenberg examines in his Longevity study include Mortality rate, Per capita and Mean age.
Frank R. Lichtenberg has included themes like Years of potential life lost, Disease and Environmental health in his Drug study.
Frank R. Lichtenberg interconnects Labour economics, Employment growth, Econometrics and Demographic economics in the investigation of issues within Productivity.
His study explores the link between Labour economics and topics such as Production that cross with problems in Capital.
He most often published in these fields:
- Life expectancy (39.29%)
- Longevity (39.92%)
- Drug (34.87%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer (21.22%)
- Years of potential life lost (22.48%)
- Cancer mortality (17.23%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer, Years of potential life lost, Cancer mortality, Mortality rate and Mean age.
His research on Cancer also deals with topics like
- Incidence that intertwine with fields like Developing country,
- Relative mortality, Research design, Environmental health, Medical prescription and Competition most often made with reference to Drug.
His Cancer mortality study deals with Health economics intersecting with Family medicine.
His research integrates issues of Medical expenditure and Actuarial science in his study of Mean age.
His studies in Medical expenditure integrate themes in fields like Hospital utilization, Life expectancy and Longevity.
The concepts of his Longevity study are interwoven with issues in Economic growth and Per capita.
Between 2013 and 2021, his most popular works were:
- Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009 (37 citations)
- The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009. (32 citations)
- Has medical innovation reduced cancer mortality (28 citations)
In his most recent research, the most cited papers focused on:
- Health care
- Finance
- Cancer
Frank R. Lichtenberg mainly focuses on Years of potential life lost, Cancer, Mortality rate, Incidence and Longevity.
His Years of potential life lost research includes themes of Actuarial science, Fixed effects model, Mean age, Gross domestic product and Cancer survival.
His Cancer research focuses on Drug and how it relates to Sample size determination, Relative mortality and Age of onset.
His research investigates the connection with Mortality rate and areas like Cancer mortality which intersect with concerns in Health economics and Disease.
His Life expectancy research extends to the thematically linked field of Longevity.
His Life expectancy research also works with subjects such as
- Hospital utilization most often made with reference to Medical expenditure,
- Per capita and related Per capita income and Immunization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
